• Return to Headlines

Upgrade Alert for Hologic (HOLX)

By James Quinn

Hologic (NASDAQ:HOLX) was upgraded from Hold to Buy at Evercore ISI today. The stock closed yesterday at $38.27 on volume of 4.5 million shares, below average daily volume of 5.5 million.

Hologic, Inc. develops, manufactures, and markets x-ray systems. The Company makes x-ray bone densitometers that measure the precise bone density for use in the diagnosing of metabolic bone diseases such as osteoporosis.

Hologic share prices have moved between a 52-week high of $43.00 and a 52-week low of $29.71 and closed yesterday at 29% above that low price at $38.27 per share. Over the last five market days, the 200-day moving average (MA) has gone down 0.2% while the 50-day MA has remained constant.

Hologic (NASDAQ:HOLX) has potential upside of 9.1% based on a current price of $38.27 and analysts' consensus price target of $41.75. The stock should find initial support at its 200-day moving average (MA) of $37.56 and further support at its 50-day MA of $35.23.

SmarTrend is tracking the current trend status for Hologic and will alert subscribers who have HOLX in their portfolio or watchlist when shares have changed trend direction.

Keywords: analyst upgrades/downgrades Hologic

Ticker(s): HOLX